Sponsor or institution
Clinical trials and research at Boston Scientific Corporation
As of November 12, 2026, Find a Trial lists 32 clinical trials run by Boston Scientific Corporation that are recruiting, at sites in 37 countries (most in United States (17), Spain (12), Belgium (10)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 32Clinical trials
- 37Countries
Newest trials
All recruiting trials (32)
-
FARAFLEX Mapping and Pulsed Field Ablation for Atrial Fibrillation
This trial tests the FARAFLEX Mapping and PFA System to see if it can safely help adults with drug-refractory paroxysmal or persistent atrial fibrillation.
-
Fainting Detection and Early Warning Using a Wearable Monitor
This study tests whether signals from a wearable Holter monitor can reflect the severity of orthostatic intolerance in people with fainting disorders.
-
Combined CM and STN Stimulation for Motor Epilepsy
This pilot study tests whether pairing CM thalamus DBS with STN DBS can help adults with drug‑resistant motor epilepsy.
-
Transcarotid Neuroprotection System with TCAR for Carotid Artery Disease
This registry tests how well the ENROUTE Transcarotid Neuroprotection System works in real-world patients with extracranial carotid artery disease who are treated with TCAR using Boston Scientific stents.
-
FARAPULSE pulsed-field waveform treatment for paroxysmal and persistent atrial fibrillation
This will test new pulsed electrical waveforms delivered by the FARAPULSE PFA system to treat adults with paroxysmal or persistent atrial fibrillation.
-
TheraSphere Y-90 glass microsphere treatment for liver tumors in Japan
This will test whether TheraSphere Y-90 glass microspheres are safe and helpful for Japanese adults with primary or secondary liver cancer who are not candidates for standard treatments.
-
Acquiring 2D ICE Images with the CHORUS IDx System During Atrial Arrhythmia Ablation
This study tests whether the CHORUS IDx system can acquire 2D intracardiac echocardiography images during an ablation for atrial arrhythmias.
-
Concomitant Pulsed Field Ablation and Left Atrial Appendage Closure in AF Patients
In patients with atrial fibrillation who need both ablation and left atrial appendage closure, this study tests doing both procedures in a single intervention using FARAPULSE PFA and a WATCHMAN FLX device.
-
Watchman Elite Left Atrial Appendage Closure Device in AF patients seeking a non-drug option
This study tests whether the Watchman Elite LAAC device can safely and effectively reduce stroke risk in people with non-valvular atrial fibrillation who want a non-pharmacologic alternative to anticoagulation.
-
OverStitch NXT Endoscopic Suture System for Endoscopic Sleeve Gastrectomy in Obesity
This trial tests whether the OverStitch NXT endoscopic suture system, used with lifestyle management, helps people with obesity lose weight compared to lifestyle management alone.
-
Orbera365 Intragastric Balloon System for Weight Loss
This trial tests whether placing the Orbera365 balloon plus lifestyle support helps adults with obesity lose weight compared to lifestyle support alone.
-
Time‑variant pulse spinal cord stimulation for chronic low back and leg pain
This trial will test whether time‑variant pulse spinal cord stimulation using the Boston Scientific WaveWriter Alpha system can reduce chronic low back or leg pain in adults who have not found relief from other treatments.
-
Pulmonary vein isolation alone versus pulmonary vein isolation plus linear ablation for persistent atrial fibrillation
This study will test whether adding linear ablation to pulmonary vein isolation using pulsed field ablation helps people with persistent atrial fibrillation stay in normal heart rhythm.
-
Left bundle branch area pacing versus conventional cardiac resynchronization therapy for heart failure
This study will test whether left bundle branch area pacing (LBBAP) works as well as or better than conventional cardiac resynchronization therapy (CRT) in adults with NYHA II–IV heart failure and reduced ejection fraction who are receiving a CRT‑D device.
-
Orbera365 intragastric balloon for weight loss and safety during up to 12 months in place
This registry will collect routine clinic data to see if the Orbera365 intragastric balloon is safe and helpful for adults with obesity (BMI 30–50, or higher with comorbidities) when left in place for up to 12 months.
-
Endo-SPONGE treatment for lower pelvic anastomotic or Hartmann's stump leakages
This study will test whether Endo-SPONGE endoscopic vacuum therapy can safely help close anastomotic or Hartmann's stump leakages in adults after colorectal surgery.
-
Transoral outlet reduction plus lifestyle program for weight regain after gastric bypass
This trial will test whether adding a transoral outlet reduction procedure to an intensive lifestyle program helps people who regained weight after Roux-en-Y gastric bypass lose more weight than lifestyle changes alone.
-
AGENT drug-coated balloon versus standard PCI for de novo coronary lesions
This trial tests whether the AGENT drug-coated balloon is a safe and effective alternative to drug-eluting stents or standard balloon angioplasty for adults with new (de novo) coronary artery lesions undergoing PCI.
-
Minimally-invasive procedure for vertebrogenic back pain
This study looks at how well the Intracept™ procedure works for people with chronic low-back pain caused by vertebrogenic issues.
-
Real-world use of the EkoSonic Endovascular System for acute pulmonary embolism in Chinese patients
This study tests whether the EkoSonic Endovascular System is safe and effective for Chinese patients with acute pulmonary embolism in routine clinical care.
-
Outcomes of radiofrequency ablation for movement disorders
This study looks at how well a specific treatment called radiofrequency ablation works for people with movement disorders like Parkinson's disease and essential tremor.
-
Evaluating a new catheter for treating persistent atrial fibrillation
This study is testing a new catheter to see if it can safely help people with persistent atrial fibrillation who haven't found relief from other treatments.
-
Evaluating the TheraSphere device for recurrent glioblastoma
This study is testing a new device that delivers targeted radiation directly to tumors in patients with recurrent glioblastoma to see if it can improve treatment results and reduce side effects.
-
Registry for monitoring cardiac device performance and safety
This study is collecting information on how well Boston Scientific heart devices work and their safety for patients who have recently had procedures with these devices.
-
Registry for real-world treatment of peripheral vascular lesions
This study is trying to see how well drug-eluting devices from Boston Scientific work for treating peripheral vascular diseases in a wide range of patients in real-world settings.
-
Registry of Deep Brain Stimulation for Essential Tremor
This study is collecting information from people with Essential Tremor who are using a specific brain stimulation device to see how well it works in real life.
-
Evaluating outcomes of Deep Brain Stimulation for movement disorders
This study looks at how well Deep Brain Stimulation works for people with Parkinson's Disease, Essential Tremor, and Dystonia by reviewing past patient records.
-
Evaluating new software features for cardiac mapping
This study tests new software features to see if they can make heart mapping during procedures for fast heart rhythms easier and more accurate for patients.
-
Observing outcomes of Vercise DBS for treating dystonia
This study looks at how well the Vercise Deep Brain Stimulation system helps people with dystonia feel better and improve their quality of life.
-
Registry of outcomes for the Vercise DBS System in Parkinson's disease
This study is collecting information from around the world to see how well the Vercise Deep Brain Stimulation system helps people with Parkinson's disease manage their symptoms and improve their quality of life.
-
Evaluating long-term effectiveness of neurostimulation therapy for pain
This study is testing how well Boston Scientific's neurostimulation therapy works for managing pain over the long term in people who have had a positive trial with the treatment.
-
Evaluating treatment outcomes for chronic pain
This study looks at past medical records to see how different treatments for chronic pain have worked for various groups of patients.
Quick answers
How many clinical trials run by Boston Scientific Corporation are recruiting right now?
32, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 37 countries. The most sites are in United States (17 trials), Spain (12 trials), Belgium (10 trials), Italy (10 trials), Germany (10 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.